Boston Scientific Corporation (FRA:BSX)
86.60
-0.20 (-0.23%)
At close: Nov 28, 2025
Boston Scientific Employees
Boston Scientific had 53,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.42% compared to the previous year.
Employees
53,000
Change (1Y)
5,000
Growth (1Y)
10.42%
Revenue / Employee
€311,154
Profits / Employee
€44,882
Market Cap
128.81B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 53,000 | 5,000 | 10.42% |
| Dec 31, 2023 | 48,000 | 3,000 | 6.67% |
| Dec 31, 2022 | 45,000 | 4,000 | 9.76% |
| Dec 31, 2021 | 41,000 | 3,000 | 7.89% |
| Dec 31, 2020 | 38,000 | 2,000 | 5.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 73,840 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,730 |
Boston Scientific News
- 9 days ago - BSX Quantitative Stock Analysis - Peter Lynch - Nasdaq
- 10 days ago - Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know - Nasdaq
- 10 days ago - Boston Scientific (BSX) Down 5.7% Since Last Earnings Report: Can It Rebound? - Nasdaq
- 12 days ago - Boston Scientific (BSX) Announces 2026 Compensation Plans to Drive Performance and Shareholder Value - GuruFocus
- 12 days ago - BSX's Neuromodulation Prospect Looks Strong: What's Behind It? - Nasdaq
- 13 days ago - $100 Invested In Boston Scientific 15 Years Ago Would Be Worth This Much Today - Benzinga
- 13 days ago - Boston Scientific Corporation (BSX) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript - Seeking Alpha
- 14 days ago - Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion - Nasdaq